norbuprenorphine

更新时间:2024-01-02 12:03:32

norbuprenorphine结构式
norbuprenorphine结构式
品牌特惠专场
常用名 norbuprenorphine 英文名 norbuprenorphine
CAS号 78715-23-8 分子量 413.55000
密度 1.27g/cm3 沸点 562.7ºC at 760 mmHg
分子式 C25H35NO4 熔点 221-224ºC
MSDS N/A 闪点 294.1ºC
符号 GHS02 GHS06 GHS08
GHS02, GHS06, GHS08
信号词 Danger

 norbuprenorphine名称

英文名 norbuprenorphine
英文别名 更多

 norbuprenorphine物理化学性质

密度 1.27g/cm3
沸点 562.7ºC at 760 mmHg
熔点 221-224ºC
分子式 C25H35NO4
分子量 413.55000
闪点 294.1ºC
精确质量 413.25700
PSA 70.95000
LogP 3.62020
折射率 1.627

 norbuprenorphine安全信息

符号 GHS02 GHS06 GHS08
GHS02, GHS06, GHS08
信号词 Danger
危害声明 H225-H301 + H311 + H331-H370
警示性声明 P210-P260-P280-P301 + P310-P311
危险品运输编码 UN1230 - class 3 - PG 2 - Methanol, solution

 norbuprenorphine合成线路

~80%

norbuprenorphine结构式

norbuprenorphine

78715-23-8

文献:MALLINCKRODT INC.; ALLEN, Brenda, E.; JARVI, Esa, T.; KALOTA, Dennis, J.; MEYER, James, R.; TOMAZI, Keith, G.; MANNINO, Anthony; ORR, Brian Patent: WO2010/39220 A1, 2010 ; Location in patent: Page/Page column 30-31 ;

~16%

norbuprenorphine结构式

norbuprenorphine

78715-23-8

文献:RECKITT BENCKISER HEALTHCARE (UK) LIMITED Patent: WO2003/95458 A1, 2003 ; Location in patent: Page/Page column 10; 11 ;

~41%

norbuprenorphine结构式

norbuprenorphine

78715-23-8

文献:MacHara, Ales; Werner, Lukas; Endoma-Arias, Mary Ann; Cox, D. Phillip; Hudlicky, Tomas Advanced Synthesis and Catalysis, 2012 , vol. 354, # 4 p. 613 - 626

~35%

norbuprenorphine结构式

norbuprenorphine

78715-23-8

文献:MacHara, Ales; Werner, Lukas; Endoma-Arias, Mary Ann; Cox, D. Phillip; Hudlicky, Tomas Advanced Synthesis and Catalysis, 2012 , vol. 354, # 4 p. 613 - 626

~%

norbuprenorphine结构式

norbuprenorphine

78715-23-8

文献:MacHara, Ales; Werner, Lukas; Endoma-Arias, Mary Ann; Cox, D. Phillip; Hudlicky, Tomas Advanced Synthesis and Catalysis, 2012 , vol. 354, # 4 p. 613 - 626

~%

norbuprenorphine结构式

norbuprenorphine

78715-23-8

文献:MacHara, Ales; Werner, Lukas; Endoma-Arias, Mary Ann; Cox, D. Phillip; Hudlicky, Tomas Advanced Synthesis and Catalysis, 2012 , vol. 354, # 4 p. 613 - 626

~%

norbuprenorphine结构式

norbuprenorphine

78715-23-8

文献:MacHara, Ales; Werner, Lukas; Endoma-Arias, Mary Ann; Cox, D. Phillip; Hudlicky, Tomas Advanced Synthesis and Catalysis, 2012 , vol. 354, # 4 p. 613 - 626

 norbuprenorphine上下游产品

norbuprenorphine上游产品  2

norbuprenorphine下游产品  1

 norbuprenorphine文献25

更多文献
P-glycoprotein is a major determinant of norbuprenorphine brain exposure and antinociception.

J. Pharmacol. Exp. Ther. 343(1) , 53-61, (2012)

Norbuprenorphine is a major metabolite of buprenorphine and potent agonist of μ, δ, and κ opioid receptors. Compared with buprenorphine, norbuprenorphine causes minimal antinociception but greater res...

Chemical and enzyme-assisted syntheses of norbuprenorphine-3-β-D-glucuronide.

Bioconjug. Chem. 22(4) , 752-8, (2011)

Norbuprenorphine-3-β-d-glucuronide (nBPN-3-β-d-G, 1) is a major phase II metabolite of buprenorphine, a pharmaceutical used for the treatment of opioid addiction. The pharmacological activity of compo...

Preliminary buprenorphine sublingual tablet pharmacokinetic data in plasma, oral fluid, and sweat during treatment of opioid-dependent pregnant women.

Ther. Drug Monit. 33(5) , 619-26, (2011)

Buprenorphine is currently under investigation as a pharmacotherapy to treat pregnant women for opioid dependence. This research evaluates buprenorphine (BUP), norbuprenophine (NBUP), buprenorphine-gl...

 norbuprenorphine英文别名

6-Methylamino-4,4-diphenyl-3-heptanol-acetat
7a-[(S)-1-hydroxy-1,2,2-trimethylpropyl]-6,14-endo-ethano-6,7,8,14-tetrahydronororipavine
Noracetylmethadol
paracymethadol
Noracetylmethadone
Noracymethadole